JP2023550628A5 - - Google Patents
Info
- Publication number
- JP2023550628A5 JP2023550628A5 JP2023530833A JP2023530833A JP2023550628A5 JP 2023550628 A5 JP2023550628 A5 JP 2023550628A5 JP 2023530833 A JP2023530833 A JP 2023530833A JP 2023530833 A JP2023530833 A JP 2023530833A JP 2023550628 A5 JP2023550628 A5 JP 2023550628A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- antigen
- binding molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063117383P | 2020-11-23 | 2020-11-23 | |
| US63/117,383 | 2020-11-23 | ||
| PCT/US2021/060369 WO2022109403A1 (en) | 2020-11-23 | 2021-11-22 | Antigen-binding molecules and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550628A JP2023550628A (ja) | 2023-12-04 |
| JP2023550628A5 true JP2023550628A5 (cg-RX-API-DMAC7.html) | 2024-11-28 |
Family
ID=81709767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530833A Pending JP2023550628A (ja) | 2020-11-23 | 2021-11-22 | 抗原結合分子およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230416356A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4247848A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023550628A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230118864A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116981691A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021383841A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3199586A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022109403A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023379469A1 (en) * | 2022-11-15 | 2025-05-22 | Purdue Research Foundation | Canine pd-l1 antibody, antigen binding fragments thereof, and methods of use thereof |
| CN118063607B (zh) * | 2024-03-16 | 2026-08-07 | 珠海市丽珠单抗生物技术有限公司 | 抗犬il-31抗体及其用途 |
| GB202405576D0 (en) * | 2024-04-19 | 2024-06-05 | 272Bio Ltd | VHH antibodies |
| CN121362250A (zh) * | 2024-07-19 | 2026-01-20 | 普米斯生物技术(珠海)有限公司 | 抗il-31抗体、其药物组合物及用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2796466T1 (en) * | 2007-12-07 | 2018-01-31 | Zymogenetics, Inc. | Molecules of Humanized Specifics Specifiable for IL-31 |
| WO2009138494A2 (en) * | 2008-05-15 | 2009-11-19 | Ablynx N.V. | Amino acid sequences directed against toll-like receptors and polypeptides comprising the same for the treatment of diseases related to toll-like receptors |
| US8790651B2 (en) * | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| EP2981286A4 (en) * | 2013-04-05 | 2016-08-24 | Hoffmann La Roche | ANTI-IL-4 ANTIBODIES AND BISPECIFIC ANTIBODIES AND USES THEREOF |
| MA40824A (fr) * | 2014-10-22 | 2017-08-29 | Saiba Gmbh | Particules de cmv de type virus modifié |
| KR102693806B1 (ko) * | 2014-12-11 | 2024-08-09 | 피에르 파브르 메디카먼트 | 항-c10orf54 항체들 및 그들의 용도들 |
| GB201621439D0 (en) * | 2016-12-16 | 2017-02-01 | Singapore Health Services Pte Ltd And Nat Univ Of Singapore | IL-11Ra Antibodies |
| US10093731B2 (en) * | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| GB201710835D0 (en) * | 2017-07-05 | 2017-08-16 | Ucl Business Plc | ROR1 Antibodies |
| US20210079054A1 (en) * | 2017-12-11 | 2021-03-18 | Ubi Us Holdings, Llc. | Peptide immunogens of il-31 and formulations thereof for the treatment and/or prevention of atopic dermatitis |
| CA3093709C (en) * | 2018-03-16 | 2024-03-26 | Zoetis Services Llc | Peptide vaccines against interleukin-31 |
| JP7449234B2 (ja) * | 2018-03-16 | 2024-03-13 | ゾエティス・サービシーズ・エルエルシー | 獣医学使用のためのインターロイキン31モノクローナル抗体 |
| WO2019183449A1 (en) * | 2018-03-23 | 2019-09-26 | North Carolina State University | Methods and compositions for allergic disorders |
| US20190300610A1 (en) * | 2018-03-29 | 2019-10-03 | Hummingbird Bioscience Pte. Ltd. | Vista antigen-binding molecules |
-
2021
- 2021-11-22 JP JP2023530833A patent/JP2023550628A/ja active Pending
- 2021-11-22 EP EP21895765.2A patent/EP4247848A4/en active Pending
- 2021-11-22 KR KR1020237020496A patent/KR20230118864A/ko active Pending
- 2021-11-22 CA CA3199586A patent/CA3199586A1/en active Pending
- 2021-11-22 WO PCT/US2021/060369 patent/WO2022109403A1/en not_active Ceased
- 2021-11-22 CN CN202180091195.3A patent/CN116981691A/zh active Pending
- 2021-11-22 US US18/037,938 patent/US20230416356A1/en active Pending
- 2021-11-22 AU AU2021383841A patent/AU2021383841A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6881557B2 (en) | Super humanized antibodies | |
| EP3689909A1 (en) | Tigit antibody, antigen-binding fragment thereof, and medical use thereof | |
| CN110669135B (zh) | 一种双特异性抗体及其用途 | |
| JP5738294B2 (ja) | 抗vegfモノクローナル抗体およびその抗体を含む薬学的組成物 | |
| US20050288491A1 (en) | Super-humanized antibodies against respiratory syncytial virus | |
| JP2020536532A5 (cg-RX-API-DMAC7.html) | ||
| JP7821159B2 (ja) | Bcmaと結合する単一可変ドメイン及び抗原結合分子 | |
| RU2004121673A (ru) | Человеческие полипептиды, вызывающие или опосредующие лизис клеток, включая клетки лимфоидных опухолей | |
| JP2005537009A (ja) | 免疫系分子をヒト化する方法 | |
| CN118063619A (zh) | 工程化的异源二聚体蛋白质 | |
| HRP20120701T1 (hr) | Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1 | |
| JP2021530244A5 (cg-RX-API-DMAC7.html) | ||
| JP2018522888A5 (cg-RX-API-DMAC7.html) | ||
| CN111808193B (zh) | 可结合人cd38的纳米抗体及其应用 | |
| JP2005528914A5 (cg-RX-API-DMAC7.html) | ||
| JP2022512646A5 (cg-RX-API-DMAC7.html) | ||
| CN110461874B (zh) | 抗gitr抗体、其抗原结合片段及其医药用途 | |
| WO2022228183A1 (zh) | 抗siglec15抗体及其制备方法和用途 | |
| JP2021518748A5 (cg-RX-API-DMAC7.html) | ||
| CN110913894A (zh) | 抗csf-1r抗体、其抗原结合片段及其医药用途 | |
| US9273138B2 (en) | Humanized forms of monoclonal antibodies to human GnRH receptor | |
| Ren et al. | The role of the light chain in the structure and binding activity of two cattle antibodies that neutralize bovine respiratory syncytial virus | |
| CN116284408A (zh) | 结合人muc17的抗体、其制备方法及用途 | |
| JP2019514343A5 (cg-RX-API-DMAC7.html) | ||
| KR940006602A (ko) | 면역글로불린 이소타입에 대한 재조형 모노클로날 항체 |